 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 1999, 19(24):10757-10766
Neuregulin Induces GABAA Receptor Subunit Expression
and Neurite Outgrowth in Cerebellar Granule Cells
Heather I.
Rieff1,
Lori
T.
Raetzman3,
Douglas W.
Sapp4,
Hermes H.
Yeh4,
Ruth E.
Siegel2, and
Gabriel
Corfas1
1 Division of Neuroscience and Department of Neurology,
Children's Hospital and Harvard Medical School, and Program in
Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, 2 Department of Pharmacology, Case Western Reserve
University, School of Medicine, Cleveland, Ohio 44106-4965, 3 Department of Neuroscience, Case Western Reserve
University, School of Medicine, Cleveland, Ohio 44106-4975, and
4 Department of Pharmacology and Neurology, Program in
Neuroscience, University of Connecticut Health Center, Farmington,
Connecticut 06030
 |
ABSTRACT |
Neuregulin (NRG), a growth and differentiation factor that signals
via erbB receptor tyrosine kinases, has been shown to have biological
effects in both the CNS and the peripheral nervous system. We
report here that erbB4 is expressed in mature cerebellar granule cells,
where it appears to be concentrated at the granule cell postsynaptic
terminals. We also show that one form of NRG, Ig-NRG, plays a crucial
role in aspects of cerebellar granule cell development in
vitro. First, Ig-NRG treatment of granule cells in culture
selectively induces the expression of the GABAA receptor
2 subunit. This increase in subunit expression is paralleled by an
increase in functional GABAA receptors. In contrast to its effects on GABAA receptor subunit expression, Ig-NRG does
not upregulate NMDA receptor N2B and N2C subunit expression. Second, we
demonstrate that Ig-NRG also enhances neurite outgrowth from cultured
granule cells. Ig-NRG does not, however, act as a survival factor for
the granule cells. We have compared the effect of Ig-NRG with the
effects of brain-derived neurotrophic factor (BDNF), a neurotrophin
that exerts specific effects on granule cells in culture, and found
that BDNF does not mimic the effects of Ig-NRG on GABAA
receptor subunit expression. Our results show that Ig-NRG has specific
effects on granule cell development and maturation and may regulate
these processes in vivo.
Key words:
erbB receptors; neuregulin; cerebellum; neurite
outgrowth; GABAA receptors; neuronal differentiation; cerebellar granule cells
 |
INTRODUCTION |
The neuregulins (NRGs) are members
of the epidermal growth factor (EGF) superfamily of growth and
differentiation factors (Lemke, 1996 ). NRG (also called NRG1), the
first member of the NRG family, is also known by several other names
because it was identified on the basis of different biological
activities, including the activation of the HER2/erbB2/neu
tyrosine kinase receptor [neu differentiation factor (Peles et al.,
1992 ); heregulin (Holmes et al., 1992 )], the induction of
acetylcholine receptor expression in skeletal muscle [acetylcholine
receptor-inducing activity (Falls et al., 1993 )], and the induction of
proliferation of Schwann cells [glial growth factor (Marchionni et
al., 1993 )]. NRG appears to be critical for the development of several
cell types and organs, including the heart, the peripheral nervous
system (PNS) and CNS (for review, see Lemke, 1996 ). Even though
the CNS is the site of highest expression of NRG (Holmes et al., 1992 )
and of one of the NRG receptors, erbB4 (Plowman et al., 1993 ), the
roles of these molecules in neuronal differentiation in the brain
remain largely unknown.
One of the processes proposed to be regulated by NRG is the formation
of synapses, an hypothesis that has been tested in the PNS. In
particular, NRG is expressed in spinal cord motoneurons, and it
increases the synthesis of nicotinic acetylcholine receptors (nAChRs)
(Falls et al., 1993 ) and the number of Na+
channels (Corfas and Fischbach, 1993 ) in skeletal muscle, suggesting that it is important in the formation of the neuromuscular junction. Moreover, animals with a single copy of the NRG gene are myasthenic, indicating that NRG plays a role in the regulation of muscle nAChRs in vivo (Sandrock et al., 1997 ). NRG is also expressed in
preganglionic neurons in the spinal cord, and it has been shown to
control the levels of nACh and GABAA receptors in
their postsynaptic targets, the sympathetic neurons (Yang et al.,
1998 ).
The role of NRG in regulating neuronal maturation and synapse formation
in the CNS has been studied to a lesser extent. To determine the
effects of NRG on CNS neurons, we tested the responses of dissociated
cerebellar granule cells to NRG stimulation. We studied cerebellar
granule neurons because in vivo NRG and erbB4 are expressed
in a pattern consistent with these molecules being involved in
interactions between granule cells and their synaptic inputs, the Golgi
cells and the mossy fibers. Mature granule cells express high levels of
erbB4 mRNA (Elenius et al., 1997 ), and these are the only neurons in
the adult cerebellum that express this receptor. It has also been
demonstrated that the presynaptic inputs to granule cells, the
cerebellar Golgi cells and the neurons of the pontine nuclei, express
NRG mRNA (Corfas et al., 1995 ). Moreover, NRG immunoreactivity has been
shown to be concentrated at the glomeruli, the synapses formed by
granule cell dendrites, pontine-derived mossy fiber terminals, and
Golgi cell terminals (Sandrock et al., 1995 ).
We used an in vitro system of dissociated cerebellar granule
cells to determine the effects of Ig-NRG, an NRG isoform that contains
an immunoglobulin-like domain, on neuronal survival, neurite outgrowth,
and neurotransmitter receptor expression. We found that Ig-NRG
selectively upregulates the level of GABAA
receptor 2 subunit expression and enhances GABA-evoked currents in
the granule cells. In contrast, Ig-NRG does not affect the expression of NMDA receptor N2B and N2C subunits (NR2B and NR2C). We found that
the role of Ig-NRG in cerebellar granule cell differentiation differs
from that of brain-derived neurotrophic factor (BDNF), a factor known
to mediate granule cell survival (Segal et al., 1992 ; Lindholm et al.,
1993 ) and neurite outgrowth (Segal et al., 1995 ). While both Ig-NRG and
BDNF enhance neurite outgrowth from the granule cells, BDNF does not
induce the expression of the GABAA receptor
subunits examined in this study. In contrast to BDNF, Ig-NRG is not a
survival factor for these cells. Our results suggest that, in
vivo, NRG may regulate morphological and functional aspects of
granule cells and their synapses and that these effects are distinct
from those of BDNF.
 |
MATERIALS AND METHODS |
Recombinant NRG
The form of NRG used in these studies is the form containing an
Ig-like domain [NDF 1 (14-246); Amgen, Thousand Oaks, CA]. For
these studies we used a range of concentrations of Ig-NRG. The
Kd for NRG binding to its receptors is
~105 pM (Holmes et al., 1992 ). Thus, 1 nM NRG is a saturating concentration (Holmes et
al., 1992 ; Dong et al., 1995 ), and this concentration has been shown to
affect several cell types (Martinou et al., 1991 ; Dong et al., 1995 ;
Canoll et al., 1996 ; Rio et al., 1997 ). In some experiments we used
higher concentrations of Ig-NRG (2-5 nM), because a previous report suggested that higher concentrations of
Ig-NRG may be required for certain biological effects on granule cells
(Ozaki et al., 1997 ). The ED50 for BDNF's
biological effects lies between 0.3 and 3 ng/ml. Thus in our
experiments we used a saturating concentration of this factor (20-50
ng/ml), the same range of concentrations of BDNF that are usually used.
Dissociated cerebellar granule cell cultures
Cerebella were removed from postnatal day 6 (P6) Sprague Dawley
rats in ice-cold PBS. The tissue was cleaned of meninges, cut into
small pieces, and digested in 0.05% trypsin (Sigma, St. Louis, MO) for
15 min at 37°C. After centrifugation, the tissue was further
triturated in solution containing 4000 units of DNase (Worthington,
Freehold, NJ). After allowing larger, undissociated pieces of tissue to
settle, the supernatant was harvested, and cells were plated on tissue
culture dishes coated with 0.1 mg/ml poly-D-lysine
(Collaborative Biomedical Products, Bedford, MA) and 5 µg/ml laminin
(Collaborative Biomedical Products). Cells were grown in serum-free
supplemented media [Neurobasal media (Life Technologies, Gaithersburg,
MD), B27 supplement (Life Technologies), 6 gm/l D-glucose,
2 mM L-glutamine, 100 U/ml penicillin and 100 U/ml streptomycin (pen-strep), and 25 mM KCl] (Gault and
Siegel, 1997 ), unless noted otherwise. Granule cells were treated with Ig-NRG (1-5 nM) or BDNF (20 or 50 ng/ml; Amgen) at the
time of plating. In experiments in which granule cells were cultured
for >2 d, cells were treated with 60 µM
5-fluoro-2'-deoxyuridine at 2 d in vitro (DIV) to
inhibit proliferation of non-neuronal cells.
Granule cell reaggregate cultures
Reaggregate cultures of granule cells were obtained using the
method of Segal et al. (1995) with slight modifications. Granule cells
were prepared as described above. Dissociated cells were incubated for
24 hr on uncoated tissue culture dishes in media containing DMEM, 10%
fetal bovine serum, D-glucose, pen-strep, and glutamine.
Then, reaggregates were washed in serum-free media [Neurobasal media,
N2 supplement (Life Technologies), glucose, pen-strep, and glutamine]
and plated in this media onto dishes coated with 500 µg/ml
poly-D-lysine. At the time of replating, the reaggregates
were treated with 1 nM Ig-NRG, 5 nM Ig-NRG, or 20 ng/ml BDNF. After 22 hr, the reaggregates were fixed and stained with a class III -tubulin antibody (1:1000; Sigma) and a
Cy3-conjugated secondary antibody (1:1000; Jackson ImmunoResearch, West
Grove, PA) to visualize the neurites, and neurite length was analyzed.
Reaggregates consist of a cluster of cell bodies surrounded by a halo
of neurites. To analyze neurite length, the reaggregates were visually
divided into quadrants, and the length of the longest neurite in each
quadrant was measured from the edge of the cell body cluster. The four
quadrant lengths for each reaggregate were averaged to obtain the
neurite length value for each reaggregate. Only reaggregates with a
cell body cluster between 50 and 150 µm were included in the
analysis. For each group (control, 1 nM Ig-NRG, 5 nM Ig-NRG, or BDNF) 36 reaggregates were measured in three experiments.
Survival assays
MTT assay. Dissociated granule cells were plated in
96-well plates at a density of 6 × 104 cells/well. At 4 DIV cells were washed
twice and cultured for 2 d in minimal media (BME + 0.2% BSA) with
the following treatments: 1 nM Ig-NRG, 5 nM
Ig-NRG, 20 ng/ml BDNF, or 10 µg/ml insulin. At 2 d after the
media change, MTT (0.7 mg/ml; Sigma) was added, and cells were
incubated at 37°C for 2 hr. Solubilization buffer (50%
dimethylformamide, 10% SDS, and 20% glacial acetic acid) was added,
and the cells were kept overnight at 37°C in a humidified chamber.
The next day an OD of the wells was read at 595 nm. In parallel
experiments the linearity of the assay was tested by measuring OD in
cultures containing different numbers of NIH 3T3 cells. We found that
the assay was linear within the OD range used in all our experiments.
Hoechst assay. The cells were cultured and treated in the
same conditions used for the MTT assay, except that 1 d after the addition of the trophic factors, the cells were fixed and stained with
Hoechst 33342 (Molecular Probes, Eugene, OR). The percent of apoptotic
cells was then quantified in the cultures.
Immunocytochemistry of cultured granule cells
Granule cells in 24-well plates (35-40 × 104 cells/well) were fixed in 4%
paraformaldehyde in PBS for 15-20 min at room temperature. Cells were
washed in PBS and then blocked and stained using conditions appropriate
for each antibody (see below).
Phospho-CREB. Granule cells were initially plated in
serum-containing media. At 2 DIV, the cells were serum starved for 5 hr
and then treated with 1 nM Ig-NRG for 20 min. Cells were
immediately fixed, permeabilized with PBS and 0.5% NP-40 for 10 min,
washed again, blocked in 3% BSA for 1 hr, and incubated with a
phospho-CREB antibody (1:1000) (Ginty et al., 1993 ) overnight at 4°C.
Cells were then washed and incubated with an anti-rabbit biotinylated secondary antibody (1:1000; Vector Laboratories, Burlingame, CA), and
the reaction product was visualized by diaminobenzidine reaction.
ErbB4 staining. Cells were blocked in 3% BSA and 0.1%
Triton X-100 in PBS (blocking buffer) for 1 hr at room temperature and incubated overnight at 4°C with an anti-erbB4 antibody (C-18; 1:200;
Santa Cruz Biotechnology, Santa Cruz, CA). Cells were washed with PBS,
incubated with a Cy3 anti-rabbit secondary antibody (1:1000 in blocking
buffer; Jackson ImmunoResearch) for 1 hr at room temperature, washed
again, and mounted.
Immunocytochemistry of adult rat cerebellum
Adult rats were anesthetized with CO2 and
fixed by cardiac perfusion with 4% paraformaldehyde in PBS.
Cryosections (20 µm) were blocked (3% BSA and 0.1% Triton X-100 in
PBS) for 1 hr at room temperature, followed by incubation with
polyclonal anti-erbB4 0615 or 0618 (Zhu et al., 1995 ) (1:200) and
monoclonal anti-synaptophysin (1:20; Boehringer Mannheim, Indianapolis,
IN) antibodies at 4°C overnight. The sections were washed with PBS,
and the detection procedure was performed using an anti-rabbit Cy3
secondary antibody (Jackson ImmunoResearch) and an anti-mouse Oregon
green secondary antibody (Molecular Probes) (each at 1:1000) for 1 hr
at room temperature. Slides were mounted with Gel/Mount (Biomeda
Corporation, Foster City, CA), and staining was visualized by light or
confocal microscopy. Images were captured using a digital camera (Orca; Hamamatsu) in a fluorescence microscope or by confocal microscopy (OZ
confocal microscope; Odyssey, Noran Instruments, Middleton, WI).
Western blot analysis
Phosphotyrosine Western blots were performed on whole-cell
lysates of granule cells. Granule cells (2 DIV) were treated with 1 nM Ig-NRG or vehicle (PBS) for 5 min. Cells were lysed with 2× DTT sample buffer (125 mM Tris-HCl, pH 6.8, 20%
glycerol, 6% SDS, 0.1 mg/ml bromophenol blue, and 100 mM
dithiothreitol). For the GABAA receptor 2/3
Western blot, crude membranes were prepared from granule cells. Cells
were harvested in Tris-buffered saline and centrifuged at 1000 rpm for
7 min at 4°C. The cells were homogenized with 0.5 ml of
homogenization buffer containing 25 mM Tris-HCl, pH 7.4, 5 mM EDTA, 1 mM phenylmethylsulfonyl
fluoride, 20 mg/ml leupeptin, 0.1% aprotinin, 1 mM
iodoacetamide, 200 mg/ml bacitracin, and 20 mg/ml soybean trypsin
inhibitor for 10 min on ice and then sonicated for 15-20 sec. The
cells were then centrifuged at 10,000 rpm for 30 min at 4°C, and the
pellet was resuspended in 20-25 ml of homogenization buffer. The
protein was quantified using the BCA method according to the
manufacturer's protocol (Pierce, Rockford, IL).
Aliquots of whole-cell lysates or membrane preparations were resolved
on SDS polyacrylamide gel electrophoresis and transferred to
Immobilon-P (polyvinylidene difluoride) membranes (Millipore, Bedford,
MA). The membranes were blocked and incubated with either a mouse
monoclonal anti-phosphotyrosine antibody (4G10; 1:10,000) followed by a
peroxidase-conjugated anti-mouse secondary antibody (1:20,000;
Boehringer Mannheim) or with an antibody that recognizes both the 2
and 3 (for the 2/3) subunits (bd17; Boehringer Mannheim; 1:20)
followed by peroxidase-conjugated goat anti-mouse IgG (1:1000; Kirkegaard & Perry, Gaithersburg, MD). Blots were developed with Renaissance (DuPont NEN, Boston, MA) and exposed to autoradiography film (Reflection; DuPont NEN).
Reverse transcription-PCR
Comparative reverse transcription (RT)-PCR was performed as
described previously (Behringer et al., 1996 ), with slight
modifications. RNA was prepared from dissociated granule cells (2 DIV;
plated at a density of 3.1 × 106
cells/35 mm dish) using the Ultraspec RNA Isolation Reagent (Biotecx Laboratories, Houston, TX). RNA (0.2 µg) was treated with DNase (Boehringer Mannheim) and then transcribed to cDNA using Superscript RT
(Life Technologies). The PCR reaction was performed in buffer containing [32P]dCTP and primers
specific for neurotransmitter receptors (GABAA receptors or NMDA receptors). In addition, a separate reaction was
performed in parallel for each sample, using primers specific for
elongation factor 1- (EF1- ), a transcript that remains at a
constant level over time in cultured granule cells. Each primer set was
first tested for the linearity of the PCR amplification before the
experiments. PCR reactions with all GABA receptor subunit primers were
linear between 20 and 50 cycles, and therefore 31 cycles were used in
all reactions. For the NMDA receptor subunits, reactions were linear
between 30 and 50 cycles, and therefore 36 cycles were used for
quantification. In each case primers for EF1- , which behaved
linearly between 20 and 50 cycles, were used with the same number of
cycles as that for the specific receptor subunit tested. All reactions
were run on the PTC-1000 Thermal Controller (MJ Research, Watertown,
MA) for the appropriate number of cycles: 92°C for 1 min, 55°C for
30 sec, and 72°C for 45 sec. PCR products were separated on 8%
nondenaturing polyacrylamide gels. The gels were dried and exposed to
the Molecular Dynamics Phosphor Screen (Sunnyvale, CA), and the
intensity of the bands was quantified using IPLab Gel software. The
intensity of the bands corresponding to the neurotransmitter receptor
subunits was normalized relative to the intensity of the EF1- band
in each sample and then compared among the different treatments.
Another RT-PCR protocol was also used to confirm the observed changes
in gene expression, and similar results were obtained. Briefly, 83 pg
of RNA transcribed from the bacterial plasmid SP64 (Promega, Madison,
WI) was added to each sample of granule cell RNA to control for
variability between samples. Then, primers for the gene of interest and
for SP64 were used in the same reaction, and the PCR products were
separated by gel electrophoresis. Each band was excised and measured by
scintillation counting. The level of labeling in the bands
corresponding to the neurotransmitter receptors was normalized relative
to the levels of SP64 PCR product and then compared among the different
treatments. Each RT-PCR reaction for every RNA sample was performed at
least twice.
The following primer sequences for PCR were used [(+) is
complementary to the noncoding strand, and ( ) is complementary to the
coding strand]: GABAA receptor subunits, 1
(+) = 1410-1429 and 1 ( ) = 1501-1520 (Khrestchatisky
et al., 1989 ), 2 (+) = 1808-1831 and 2 ( ) = 1882-1905 (Ymer et al., 1989 ), and 2 (+) = 1744-1768 and 2
( ) = 1807-1829 (Shivers et al., 1989 ); NMDA receptor subunits,
NR2B (+) = 4015-4034 and NR2B ( ) = 4217-4236 (Yoshioka et
al., 1996 ) and NR2C (+) = 845-864 and NR2C ( ) = 1029-1048
(Yoshioka et al., 1996 ); EF1- (+) = 313-337 and EF1- ( ) = 462-485 (Sundstrom et al., 1990 ); and SP64 (+) = 234-254 and SP64 ( ) = 344-364 (Beattie and Siegel, 1993 ).
Whole-cell patch-clamp electrophysiology and focal application of
drugs
Coverslips of cultured granule cells were affixed to a 35 mm
culture dish and bathed in an external solution containing (in mM): 137 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4. Recordings were made
at room temperature (22-24°C). Cells were visualized using an
inverted microscope equipped with Hoffman modulation-contrast optics.
Patch-clamp recording pipets were fabricated from borosilicate glass
capillary tubing with an internal filament (1.5 mm outer diameter;
Sutter Instruments, Novato, CA). The recording pipets were fire
polished to resistances ranging between 8 and 10 M using a Flaming
Brown micropipet puller (Sutter Instruments) and filled with a
recording solution containing (in mM): 140 KCl, 1.8 CaCl2, 1.0 MgCl2, and 5 HEPES, pH 7.4. Mg2+-ATP (1 mM)
was added to the recording solution to prevent possible rundown of
agonist-induced currents. Cells were voltage clamped at 60 mV.
Compensation for series resistance and liquid junction potentials was
routinely applied. Whole-cell GABA-induced currents were recorded with
an EPC-7 patch-clamp amplifier (Heka Electronics, Lambrecht, Germany).
Data were acquired, digitized, and analyzed using DATAQ/DATANAL
software (JPM Programming). Peak amplitudes of GABA-activated current
responses from each cell were derived by determining the maximal
amplitude of current responses elicited by a saturating concentration
of GABA (100 or 125 µM).
Focal application of drugs was as follows: GABA was prepared
from frozen stock and diluted in bath solution immediately before each
experiment. An eight-barrel drug pipet assembly was used to apply
drugs. Seven barrels were filled with varying concentrations of GABA
(0.1-150 µM). The eighth barrel was routinely filled
with recording solution that was applied continuously between epochs of
GABA application to clear the agonist from the immediate vicinity of
the cell and to control for possible mechanical artifacts attributable to bulk flow. The multibarrel assembly was mounted on a
micromanipulator, and the tip of the multibarrel drug pipet assembly
was navigated under microscopic control to within 2-4 µm of the cell
under study. GABA was applied via regulated pressure (<3 psi) using a
Picospritzer (General Valve, Fairfield, NJ) driven by a set of pulse
generators (A310 Accupulser; WPI). The concentrations of drugs are
those used to fill the drug barrels and represent the maximal limit to
which a cell would be exposed.
Statistical analysis
Statistical analyses were performed using StatView software. For
survival data and reaggregate data, ANOVA and Fisher's LSD tests were
performed. For single-cell neurite outgrowth data, unpaired
t tests were performed. GABAA and NMDA
receptor mRNA data were analyzed by the nonparametric Wilcoxon signed
rank test. Statistical significance was determined at the
p < 0.05 level.
 |
RESULTS |
erbB4 receptors are concentrated at glomerular synapses in the
mature cerebellum
We have shown previously by in situ hybridization that
erbB4 mRNA is highly expressed in the granule cell layer of adult mice (Elenius et al., 1997 ). To determine the subcellular localization of
erbB4, we stained sections of adult rat cerebellum with anti-erbB4 antibodies. We found that erbB4 immunoreactivity in the granule cell
layer was closely associated with the synaptic vesicle protein synaptophysin (Fig. 1), suggesting that
it is localized to the glomerular synapses. Because erbB4 is expressed
by the granule cells (Elenius et al., 1997 ), it is most likely that
this receptor is localized to their postsynaptic terminals. It has been
shown previously that the granule cell afferents, the cerebellar Golgi cells and the neurons in the pontine nucleus, express NRG (Corfas et
al., 1995 ) and that NRG protein is concentrated at the glomeruli (Sandrock et al., 1995 ). Thus, it is likely that the erbB4 receptors present in the postsynaptic side and the NRG released by the
presynaptic terminals mediate interactions between the granule cell
neurons and their presynaptic inputs. On the basis of these findings we set out to study the effects of NRG on cerebellar granule cells in vitro.

View larger version (79K):
[in this window]
[in a new window]
|
Figure 1.
erbB4 and synaptophysin immunoreactivity
colocalize at cerebellar glomeruli. A,
Top, Parasagittal sections of adult cerebellum were
stained with a monoclonal antibody to the synaptic vesicle protein
synaptophysin (Oregon green secondary antibody; left)
and polyclonal antibodies to erbB4 (0618) and visualized with a Cy3
secondary antibody (right). Bottom, The
two top images are superimposed (right),
and a bright-field image of the section is shown (left).
B, Left, Middle, Confocal
images were obtained at higher magnification of the granule cell layer
from adult cerebellum stained as described above (synaptophysin,
green; erbB4, red). Right,
Colocalization of the two proteins is shown by the
superimposition of the two images. GL, Granule cell
layer; WM, white matter. Scale bars: A,
20 µm; B, 50 µm.
|
|
Granule cells in culture respond to Ig-NRG
The NRG gene, via alternative splicing, produces many different
NRG isoforms (Lemke, 1996 ). In all of the experiments included in this
study, an isoform of NRG that contains an immunoglobulin-like domain
located N terminal to the EGF-like domain (Ig-NRG = NDF 114-246) was used. This is the isoform
expressed in the cerebellar Golgi cells and the neurons of the pontine
nucleus (Corfas et al., 1995 ) and therefore is the isoform that granule
cells are most likely exposed to in vivo.
We used cultures of granule cells obtained from P6 rat cerebella, which
are highly enriched in granule neurons derived from the external
granule cell layer (EGL) (Raetzman and Siegel, 1999 ). Although the EGL
granule cells in vivo express NRG, its expression is rapidly
downregulated as the cells mature in culture (Rio et al., 1997 ). We now
show that, accompanying the decrease in NRG expression, granule cells
express erbB4 by 2 d in vitro (Fig. 2A). These changes in
the pattern of expression of NRG and erbB4 in culture mirror those
observed as granule cells mature in vivo.

View larger version (66K):
[in this window]
[in a new window]
|
Figure 2.
Granule cells in culture express erbB4 and respond
to Ig-NRG. A, Granule cells express the erbB4 receptor.
Top, Granule cells at 2 DIV were stained with a
polyclonal anti-erbB4 antibody and a Cy3 secondary antibody.
Immunoreactivity was present in the cell bodies and processes of
the cells. Bottom, No staining was observed when the
erbB4 antibody was preincubated with a cognate peptide.
B, Ig-NRG induces p180 tyrosine phosphorylation in
granule cells. Granule cells at 2 DIV were stimulated with 1 nM Ig-NRG or vehicle (control) for 5 min. Lysates were
resolved by 5% SDS-PAGE, and the blot was probed with an
anti-phosphotyrosine antibody. The Ig-NRG-induced
tyrosine-phosphorylated band is indicated by the arrow.
C, Ig-NRG induces CREB phosphorylation in cultured
granule cells. Serum-starved granule cells were treated with Ig-NRG (1 nM for 20 min), fixed, and stained with a phospho-CREB
antibody followed by peroxidase reaction. There were significantly more
labeled cells in the Ig-NRG-treated cultures (cells appear
dark). Scale bars: A, 40 µm;
C, 50 µm.
|
|
Expression of erbB4 in the granule cells suggested that they should
respond to NRG. We found that treatment of cultured granule cells with
1 nM Ig-NRG for 5 min led to a significant and reproducible tyrosine phosphorylation of a 180 kDa protein (Fig.
2B). This band has the molecular weight of the erbB
receptors and is similar to that induced by NRG stimulation in muscle
cells (Corfas et al., 1993 ), astrocytes (Rio et al., 1997 ), and neurons
(Corfas et al., 1995 ). These results show that granule cells respond to Ig-NRG by activation of erbB receptors.
We have shown previously that the EGF-like domain of NRG can induce
phosphorylation of the transcription factor CREB in cultured cerebellar
astroglia (Rio et al., 1997 ), and similar results have been
demonstrated in Schwann cells in vitro (Taberno et al.,
1998 ). To test whether NRG induced CREB phosphorylation in cultured
granule cells, we stained untreated and Ig-NRG-treated cells with an
antibody that recognizes CREB phosphorylated in Ser133 (Ginty et al.,
1993 ). Treatment with Ig-NRG led to more than a threefold increase in the number of cells with phospho-CREB-positive nuclei (18.3 ± 11.4% labeled cells in control; 60.5 ± 3.9% in Ig-NRG-treated cells) (Fig. 2C). These results suggest that granule cells
can respond to Ig-NRG by activation of erbB receptors, which then leads
to activation of transcription factors that may regulate gene
expression in these neurons.
Ig-NRG does not support granule cell survival
Several growth factors that signal through tyrosine kinase
receptors have been shown to act as survival and differentiation factors for cerebellar granule cells (Lindholm et al., 1997 ). We
investigated the biological effects of NRG on the granule cells and
tested the specificity of these effects by comparing them with the
effects of BDNF, which supports granule cell survival (Segal et al.,
1992 ; Lindholm et al., 1993 ) and induces neurite outgrowth from granule
cells (Segal et al., 1995 ).
We first compared the effects of Ig-NRG with the effects of BDNF on
granule cell survival using two assays, an MTT assay to measure
surviving cells and Hoechst nuclear staining to quantify the number of
apoptotic cells. By the MTT assay we found that in the absence of any
other factors, BDNF increased the survival of granule cells in culture
by more than twofold (p < 0.0001) (Fig.
3A). In contrast, Ig-NRG had
no effect on granule cell survival (1 nM,
p = 0.10; 5 nM, p = 0.15) (Fig. 3A). Quantification of the percent of
apoptotic cells in the cultures showed similar results. Granule cells
were incubated under the different conditions for 24 hr, fixed, and
stained with the nuclear dye Hoechst, and apoptotic cells were
recognized by the condensation of their nuclei. Only cultures treated
with BDNF had significantly less apoptotic cells
(p = 0.014) than did control (Fig.
3B). These results show that Ig-NRG does not support granule
cell survival in vitro.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 3.
Ig-NRG is not a survival factor for
granule cells. A, Granule cells in minimal medium were
treated with 1 nM Ig-NRG, 5 nM Ig-NRG, 20 ng/ml
BDNF, or vehicle (control) for 2 d. Cell survival was then
measured by the MTT assay, and the reaction product was analyzed
spectrophotometrically. The graph shows an average OD for four
independent experiments. Cell survival was significantly increased only
by BDNF treatment (BDNF, *p < 0.0001; 1 nM NRG, p = 0.10; 5 nM NRG,
p = 0.15). B, Granule cells were
treated with 1 nM Ig-NRG, 5 nM Ig-NRG, 20 ng/ml
BDNF, or vehicle (control) for 24 hr. Cells were then fixed and stained
with Hoechst dye, and the percentage of apoptotic cells was quantified.
BDNF but not Ig-NRG treatment significantly reduced the percent of
apoptotic cells compared with control (BDNF, *p = 0.014; 1 nM Ig-NRG, p = 0.71; 5 nM Ig-NRG, p = 0.93).
|
|
Ig-NRG induces neurite outgrowth
BDNF has also been shown to induce neurite outgrowth from granule
cells in reaggregate cultures (Segal et al., 1995 ). We used a similar
culture system to study the effects of Ig-NRG on neurite outgrowth.
Granule cell reaggregates were treated for 22 hr with vehicle
(control), 1 nM Ig-NRG, 5 nM Ig-NRG, or 20 ng/ml BDNF. Cells were then fixed and stained with antibodies against
class III -tubulin antibody to visualize the neurites, and neurite length was measured. We found that neurites from granule cell reaggregates treated with Ig-NRG or BDNF were significantly longer than
those from untreated reaggregates (p < 0.0001 for all treatments) (Fig. 4). Other
parameters of neurite outgrowth including thickness of neurite bundles
and neurite fasciculation were not qualitatively different among the
treatments. To examine further the effect of Ig-NRG on neurite
outgrowth, we tested its effect on dissociated granule cells. As in the
reaggregates, Ig-NRG treatment caused a significant increase (45%
above control) in the neurite length of dissociated granule cells
(control, 52.3 ± 5.6 µm average length; 2 nM Ig-NRG, 75.7 ± 7.1 µm average length;
p = 0.01).

View larger version (30K):
[in this window]
[in a new window]
|
Figure 4.
Ig-NRG enhances neurite outgrowth from granule
cell reaggregates. A, Granule cell reaggregates were
treated with vehicle (control), 1 nM Ig-NRG, or 5 nM Ig-NRG for 22 hr. Cultures were then fixed and stained
with an antibody to class III -tubulin and visualized with a Cy3
secondary antibody. Scale bar, 100 µm. B, Ig-NRG and
BDNF significantly increase neurite outgrowth from granule cell
reaggregates. Reaggregates were treated with 1 nM Ig-NRG, 5 nM Ig-NRG, or 20 ng/ml BDNF and stained with a class III
-tubulin antibody, and neurite length was analyzed. The graph shows
a percentage increase in neurite length above control
(p < 0.0001 for all three
treatments).
|
|
Ig-NRG treatment increases GABAA receptor 2 subunit
expression in cultured granule cells
It has been shown that NRG plays an important role in the
regulation of neurotransmitter receptor expression in skeletal muscle (Harris et al., 1988 ; Martinou et al., 1991 ; Falls et al., 1993 ) and in
sympathetic neurons (Yang et al., 1998 ). It has also been reported that
NRG regulates the expression of the NR2C subunit in cerebellar slices
in culture (Ozaki et al., 1997 ). Our finding that Ig-NRG induces CREB
phosphorylation in cerebellar granule cells suggested that Ig-NRG may
activate gene transcription in these neurons. In addition, because both
NRG and erbB4 are concentrated at the cerebellar granule cell
glomeruli, we hypothesized that NRG might regulate the expression of
two neurotransmitter receptors that function at this synapse,
GABAA and NMDA receptors (Watanabe et al., 1994 ;
Wisden, 1995 ).
Previous studies have demonstrated that several
GABAA receptor subunit mRNAs are expressed in the
cerebellar granule neurons in vivo (Laurie et al., 1992a ;
Persohn et al., 1992 ) and in culture (Bovolin et al., 1992 ; Behringer
et al., 1996 ). Although the number and stoichiometry of
GABAA receptor complexes in these neurons are
unknown, 1, 2, and 2 subunits are thought to contribute to an
abundant receptor type (Benke et al., 1991 ). In addition, the
expression of these subunit mRNAs is developmentally regulated in
vivo, being expressed at low levels early in development and then
rising during the second postnatal week, the onset of extensive synapse
formation (Laurie et al., 1992b ). In contrast, the levels of these
subunit mRNAs remain low and constant in granule cell cultures prepared
at P6 and maintained for at least 10 d in culture (Behringer et
al., 1996 ). This suggests that the expression of these subunit
transcripts requires signals present in vivo that are absent
in vitro. We therefore focused on the effects of Ig-NRG on
these three subunits using comparative RT-PCR (see Materials and Methods).
Analysis of GABAA receptor subunit mRNAs in the
cultured granule cells showed that Ig-NRG (1 nM, for 2 d) specifically increases expression of the 2 subunit transcript
[162% of control (p = 0.02)] (Fig.
5A). In contrast, there were
no significant increases in the levels of 1 or 2 subunit mRNAs in
response to Ig-NRG [ 1, 128% of control (p = 0.14); 2, 102% of control (p = 0.96)] (Fig.
5A). Analysis of subunit levels after treatment with 50 ng/ml BDNF showed that BDNF did not alter the levels of any of these
GABAA receptor subunit mRNAs (Fig.
5B). Similar results were found with 20 ng/ml BDNF (data not
shown).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 5.
Ig-NRG treatment upregulates GABAA
receptor 2 subunit mRNA expression. A,
GABAA subunit mRNA levels were examined in control and
Ig-NRG-treated granule cells (2 DIV). The graph shows an average
percentage of change in mRNA level relative to control for five
independent experiments. Although levels of GABAA 2 mRNA
increased significantly in response to Ig-NRG (**p = 0.02), there was no significant effect on the levels of
GABAA 1 (p = 0.14),
GABAA 2 (p = 0.96), or NMDA
NR2B (p = 0.50) subunit mRNAs.
B, BDNF (50 ng/ml) does not induce an upregulation of
mRNA for 2 (p = 0.35), 1
(p = 0.50), or 2
(p = 0.14) GABAA subunits. The
data represent an average of three independent experiments.
|
|
The expression of NMDA receptor subunits in granule cells is also
developmentally regulated. Premigratory granule cells in the EGL
express NR1, NR2A, and NR2B subunits. After migration to the internal
granule cell layer (IGL), when the synaptic connections onto granule
cells are being formed, NR2B expression is downregulated, and the
granule cells begin to express NR2C (Watanabe et al., 1992 ). Moreover,
it has been reported that Ig-NRG treatment of cerebellar slices leads
to increases in the level of mRNA for the NR2C subunit (Ozaki et al.,
1997 ). Therefore, we tested whether Ig-NRG had any effects on NMDA
receptor subunit mRNA expression in dissociated granule cells. We found
that granule cells in culture express NR2B and that treatment with
Ig-NRG (1 nM) for 2 DIV did not alter expression of this
subunit (Fig. 5A). NR2C mRNA was expressed in both untreated
and Ig-NRG-treated cultures but at levels too low to be quantified.
Having observed a change in GABAA receptor
subunit mRNA, we investigated whether the level of subunit protein
was increased in response to Ig-NRG using an antibody that recognizes
both the GABAA 2 and 3 subunits (Benke et
al., 1991 ; Ewert et al., 1992 ). Dissociated granule cells were treated
with Ig-NRG for 3 DIV. The length of the treatment was longer than in
the experiments for detection of mRNA to allow for a delay between the
increase in mRNA level and in protein level. After treatment, cell
membranes were isolated, and the levels of GABAA
2/3 subunit expression in Ig-NRG-treated and control cells were
analyzed by Western blot. We found an increase in
GABAA 2/3 signal in the treated cells (140%
of control in two experiments) (data not shown). These results suggest
that Ig-NRG treatment leads to an increase in the levels of
GABAA 2/3 subunit protein.
Ig-NRG upregulates functional GABAA receptors
in cultured granule cells
The subunits of the GABAA receptor have
been reported to play a role in receptor assembly and targeting to the
cell membrane (Connolly et al., 1996 ; Connor et al., 1998 ; Luo et al.,
1998 ). Our observation that expression of the 2 subunit is
upregulated by Ig-NRG suggests that GABAA
receptor assembly and/or targeting may be enhanced by Ig-NRG treatment.
Such a change would result in an increase in
GABAA receptors in individual granule cells that,
in turn, would be reflected in an increased maximal response to GABA.
To test this possibility, current responses to varying concentrations
of GABA (0.1-150 µM) were recorded from
Ig-NRG-treated and control granule cells under whole-cell patch-clamp
conditions. Cultures were examined between 3 and 4 DIV, when Western
blot revealed an upregulation of the 2/3 GABAA
receptor subunit protein in the Ig-NRG-treated cultures. Treatment with
Ig-NRG resulted in a dramatic difference in the GABA response profile,
with a significant increase (greater than twofold) in the efficacy of the response (Fig. 6A).
However, this was not associated with a marked change in the potency of
the response to GABA. When comparing the maximal response to saturating
GABA concentrations (125 or 150 µM), we found
that the amplitude of the response was significantly greater in the
Ig-NRG-treated granule cells than in control cells (Ig-NRG, 0.34 ± 0.05 nA; control, 0.16 ± 0.03 nA; p < 0.005)
(Fig. 6B).

View larger version (21K):
[in this window]
[in a new window]
|
Figure 6.
Ig-NRG increases functional GABAA
receptors in cultured granule cells. A, Representative
whole-cell current responses to varying concentrations of GABA (10, 25, 50, 75, 100, and 150 µM) in a granule cell that was
treated with Ig-NRG (filled
circles) and in a control cell (open
circles). Ig-NRG (3 nM) was added to the
culture medium at the time of plating, and the GABA responses were
assayed on 3 and 4 DIV. Inset, Superimposed
computer-generated current traces recorded from the same cells
(top, Ig-NRG-treated cell; bottom,
control cell) used to generate the dose-response curves.
B, Histogram representing the binned distribution of the
amplitude of maximal current response to GABA (125 or 150 µM) recorded in granule cells from Ig-NRG-treated
(n = 20; solid bars)
and control (n = 22; open
bars) granule cells. A greater percentage of cells
examined in the Ig-NRG-treated cultures are found in the bins
representing higher maximal current response amplitudes, and the mean
response amplitude is significantly higher than that in control cells
(Ig-NRG, 0.34 ± 0.05 nA; control, 0.16 ± 0.03 nA;
p < 0.005).
|
|
 |
DISCUSSION |
NRG has different functions during early and late postnatal
cerebellar development
Cerebellar granule cells undergo a well defined pattern of
postnatal development. During the first 2 postnatal weeks in the rodent, granule cell precursors proliferate in the EGL. When these cells become postmitotic, they leave the EGL and migrate along the
radial fibers of the Bergmann glia to their final positions in the IGL.
After they reach the IGL, they form synapses with their inputs, the
terminals of the mossy fibers and the cerebellar Golgi cells.
Our findings that the pattern of expression of NRG and erbB4 changes
dramatically during cerebellar postnatal development (Rio et al., 1997 ;
this study) suggest that NRG plays different roles throughout granule
cell development, mediating events in early and late postnatal
cerebellar development. Our previous study showed that premigratory and
migrating cerebellar granule cells express NRG and that Bergmann glia
express erbB4 only during the period of granule cell migration (Rio et
al., 1997 ). We also demonstrated that erbB receptor signaling in the
glial cells in vitro is crucial for radial glial process
formation and for granule neuron migration (Rio et al., 1997 ). The
present study shows that the pattern of expression of NRG and erbB4 in
the adult cerebellum is very different. In the adult cerebellum erbB4
is not expressed by Bergmann glia but by the granule cells (see also
Elenius et al., 1997 ). At this stage NRG is not expressed by granule
cells but by cerebellar Golgi cells and the pontine neurons (Corfas et
al., 1995 ), the neurons that synapse onto the granule cells. Moreover
both NRG (Sandrock et al., 1995 ) and erbB4 appear to be concentrated at
the glomeruli, the synapses between granule cells and its presynaptic
inputs (this study). Thus, these results suggest that NRG and erbB4 may
mediate interactions between granule neurons and their synaptic inputs,
including some that may be important for granule cell development and
synapse formation.
Role of NRG in neurotransmitter receptor expression in granule
cells: GABAA receptors
The level of several GABAA receptor subunit
mRNAs increases in granule cells after their migration, when they have
reached the IGL and are establishing synaptic connections with Golgi
cell axons and mossy fiber afferents (Laurie et al., 1992a ). In
contrast, the levels of expression of these subunit mRNAs remain
constant for up to 10 d if granule cells are isolated from P6 rats
and grown in culture (Behringer et al., 1996 ). This disparity suggests that factors present in the intact cerebellum play a role in mediating the increases in GABAA receptor subunit
expression. We now show that Ig-NRG causes an upregulation of
GABAA receptor 2 subunit expression in
cultured granule cells. Among the subunits we tested, the effect of
Ig-NRG on GABAA receptors was specific to the
2 subunit. Ig-NRG treatment also results in an increase in peak GABA-activated whole-cell currents, indicating that Ig-NRG regulates expression of functional GABAA receptors in these
cells. It has been suggested that the subunits are critical for
GABAA receptor targeting to the cell surface
(Connolly et al., 1996 ; Connor et al., 1998 ; Luo et al., 1998 ). Thus,
by regulating the expression of the 2 subunit, NRG signaling may
control the total number of functional GABAA
receptors at the postsynaptic terminal of granule cells.
The effects of Ig-NRG on GABAA receptor
expression in granule cells are similar to the effects of NRG on nAChR
expression in skeletal muscle. In cultured chick myotubes, NRG
increases the number of surface nAChRs by inducing expression of the
subunit mRNA but has no effect on levels of or subunits
(Harris et al., 1988 ). In cultured mouse myotubes, NRG most strongly
upregulates the nAChR subunit, the subunit that is found only in
the adult form of the receptor (Martinou et al., 1991 ). These data
suggest that the effects of NRG on different neurotransmitter receptor types are specific to particular subunits whereas other subunits may be
regulated by other factors.
Specific effects of different isoforms of NRG on neuronal nACh and
GABAA receptor expression have been documented in
cultured chick sympathetic neurons (Yang et al., 1998 ). In these
neurons, the form of NRG that contains a cysteine-rich domain in its N terminal (CRD-NRG) increased expression of nAChRs but had no effect on
GABA currents. In contrast, the Ig-containing form of NRG, the same
form used in our experiments, induced a large increase in GABA-evoked
responses but had no effect on ACh currents. Thus, Ig-NRG appears to
have similar inductive effects on functional GABAA receptors in sympathetic neurons as in
cerebellar granule cells.
NRG and NMDA receptor expression in the cerebellum
In contrast to GABAA receptors, our
experiments showed no effects of Ig-NRG on the expression of NR2B and
NR2C subunits. However, other investigators, using a different
experimental paradigm, reported that Ig-NRG induces the expression of
NR2C subunit mRNA. When cerebellar slices dissected at P9 were
maintained in control conditions for 7 d and then treated with 5 nM Ig-NRG for 7 d, Ozaki et al. (1997) found a
dramatic increase in the levels of NR2C subunit mRNA. In these
experiments NR2C expression went from undetectable in the control to
high expression in the Ig-NRG-treated slices (Ozaki et al., 1997 ). As
in our experiments, these investigators reported no changes in the NR2B
subunit message after exposure to Ig-NRG.
We believe that the differences between our study and the one of Ozaki
et al. (1997) most likely reflect fundamental differences in the
culture systems. Our experiments were performed on enriched (97% pure)
dissociated granule cells, and the observed biological changes in the
cells are likely caused by a direct effect of Ig-NRG on the granule
neurons. The cerebellar slices, however, contain other cell types in
addition to the granule neurons, including other neurons, astrocytes,
and oligodendrocytes. Moreover, several of these other cell types,
including oligodendrocytes (Vartanian et al., 1994 ; Canoll et al.,
1996 ) and astrocytes (Pinkas-Kramarski et al., 1994 ; Anton et al.,
1997 ; Rio et al., 1997 ), have been shown to express erbB receptors and
to respond to NRG. This raises the possibility that the effect of
Ig-NRG on NR2C expression in the cerebellar slices may be indirect.
Exogenous NRG may cause other cells in the slices, such as astrocytes
or oligodendrocytes, to secrete another factor that could then act on
the granule cells to upregulate NR2C. Alternatively, it is possible
that NRG, by itself, is not sufficient to induce expression of NR2C in
granule cells. Rather, another factor, which is present in cerebellar slices but absent from pure granule cell cultures, may act in concert
with NRG to induce NR2C expression.
Comparison of the effects of NRG with the effects of BDNF
To study the specificity of NRG we compared the effects of Ig-NRG
with the effects of BDNF on granule cells. We found that each factor
has a unique set of effects on the granule cells and may therefore
regulate different aspects of granule cell development in
vivo. In agreement with previous reports, we showed that BDNF acts
as a survival factor for granule cells and enhances neurite outgrowth
from granule cell reaggregate cultures. We found, however, that BDNF
has no effect on the expression of the GABAA
receptor subunits examined. In contrast, Ig-NRG is not a survival
factor for the granule cells but like BDNF does increase neurite
outgrowth. These results suggest that the erbB and trkB receptors may
activate distinct but overlapping intracellular-signaling pathways in
granule cell neurons. The most striking and unique effect of Ig-NRG was the upregulation of GABAA receptor 2 subunit
expression, which correlated with an increased sensitivity to GABA in
the granule cells. Thus, NRG may play a central role in regulating the
formation of GABAergic synapses in the CNS and PNS.
An important event in the development of granule cells is the extension
of the dendritic processes to form connections with Golgi cells and
mossy fibers. Our finding that Ig-NRG greatly enhances neurite
outgrowth from granule cells suggests that this factor may regulate
dendritic outgrowth from granule cells in vivo. NRG has been
shown to enhance neurite outgrowth in other cells as well. NRG can
induce neuronal-like differentiation in pheochromocytoma 12 (PC12)
cells by increasing both the number of neurites per cell as well as the
length of the neurites (Corfas et al., 1994 ). Similar results were
found in PC12 cells overexpressing erbB2 or erbB3 (Gamett et al.,
1995 ). In cultured rat retinal ganglion cells, NRG increased the number
of cells with neurites as well as the number of neurites per cell
(Bermingham-McDonogh et al., 1996 ). In other systems, however,
endogenous NRG appears to suppress neurite outgrowth. When endogenous
NRG is blocked with a soluble form of erbB4 there is an increase in
neurite outgrowth either from embryonic day 17 mixed brain cultures or
from cells of the P19 neuronal cell line, which have a neuronal
phenotype after treatment with retinoic acid (Pinkas-Kramarski et al.,
1997 ). However, the presence of many non-neuronal cell types in these cultures and the fact that the soluble erbB4 may block other erbB4 ligands such as HB-EGF may contribute to the negative effect of NRG on neurite outgrowth in this system.
Many neuronal populations express erbB receptors in the CNS, and many
of their afferents express Ig-NRG. Our experiments suggest that Ig-NRG
may regulate expression of GABAA receptors in
the developing and mature CNS and may therefore play a role in the regulation of inhibitory synaptic transmission.
 |
FOOTNOTES |
Received May 7, 1999; revised Sept. 28, 1999; accepted Sept. 30, 1999.
This work was supported in part by the National Institute of
Neurological Disorders and Stroke (NINDS) Grant R01 NS35884 (G.C.), The
Klingenstein Foundation (G.C.), The EJLB Foundation (G.C.), National Alliance for Research on Schizophrenia and Depression (G.C.),
National Eye Institute Training Grant T32EY07110-05 (H.I.R.), the
Mental Retardation Research Center of the National Institutes of Health
Grants P30-HD18655 (G.C.) and NS34317 (R.E.S.), and NINDS Grant
RO1 NS24830 (H.H.Y.). We thank Amgen for providing Ig-NRG and BDNF,
Cari Lai for the erbB4 0615 and 0618 antibodies, Michael Greenberg for
the phospho-CREB antibody, and Uri Saragovi for his advice with the MTT
assay. We thank M. Bazalakova and M. Kumar for technical assistance and
David Zurakowski for help with statistical analysis.
Correspondence should be addressed to Dr. Gabriel Corfas, Division of
Neuroscience, Children's Hospital, 300 Longwood Avenue, Boston, MA
02115. E-mail: corfas_g{at}a1.tch.harvard.edu.
 |
REFERENCES |
-
Anton ES,
Marchionni MA,
Lee KF,
Rakic P
(1997)
Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex.
Development
124:3501-3510[Abstract].
-
Beattie CE,
Siegel RE
(1993)
Developmental cues modulate GABAA receptor subunit mRNA expression in cultured cerebellar granule neurons.
J Neurosci
13:1784-1792[Abstract].
-
Behringer KA,
Gault LM,
Siegel RE
(1996)
Differential regulation of GABAA receptor subunit mRNAs in rat cerebellar granule neurons: importance of environmental cues.
J Neurochem
66:1347-1353[Web of Science][Medline].
-
Benke D,
Mertens S,
Trzeciak A,
Gillessen D,
Mohler H
(1991)
GABAA receptors display association of gamma 2-subunit with alpha 1- and beta 2/3-subunits.
J Biol Chem
266:4478-4483[Abstract/Free Full Text].
-
Bermingham-McDonogh O,
McCabe K,
Reh T
(1996)
Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina.
Development
122:1427-1438[Abstract].
-
Bovolin P,
Santi MR,
Puia G,
Costa E,
Grayson D
(1992)
Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella.
Proc Natl Acad Sci USA
89:9344-9348[Abstract/Free Full Text].
-
Canoll PD,
Musacchio JM,
Hardy R,
Reynolds R,
Marchionni MA,
Salzer JL
(1996)
GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors.
Neuron
17:229-243[Web of Science][Medline].
-
Connolly C,
Wooltorton J,
Smart T,
Moss S
(1996)
Subcellular localization of gamma-aminobutyric acid type A receptors is determined by receptor beta subunits.
Proc Natl Acad Sci USA
9:9899-9904.
-
Connor J,
Boileau A,
Czajkowski C
(1998)
A GABAA receptor alpha-1 subunit tagged with green fluorescent protein requires a beta subunit for functional surface expression.
J Biol Chem
273:28906-28911[Abstract/Free Full Text].
-
Corfas G,
Fischbach GD
(1993)
The number of Na+ channels in cultured chick muscle is increased by ARIA, an acetylcholine receptor-inducing activity.
J Neurosci
13:2118-2125[Abstract].
-
Corfas G,
Falls DL,
Fischbach GD
(1993)
ARIA, a protein that stimulates acetylcholine receptor synthesis, also induces tyrosine phosphorylation of a 185-kDa muscle transmembrane protein.
Proc Natl Acad Sci USA
90:1624-1628[Abstract/Free Full Text].
-
Corfas G,
Krauss R,
Erickson CA,
Wietasch K,
Plowman G,
Fischbach GD
(1994)
ARIA induces differentiation of PC12 cells.
Soc Neurosci Abstr
20:669.
-
Corfas G,
Rosen KM,
Aratake H,
Krauss R,
Fischbach GD
(1995)
Differential expression of ARIA isoforms in the rat brain.
Neuron
14:103-115[Web of Science][Medline].
-
Dong Z,
Brennan A,
Liu N,
Yarden Y,
Lefkowitz G,
Kirsky R,
Jessen KR
(1995)
Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors.
Neuron
15:585-596[Web of Science][Medline].
-
Elenius K,
Corfas G,
Subruto P,
Choi CJ,
Rio C,
Plowman GD,
Klagsbrun M
(1997)
A novel juxtamembrane domain isoform of HER4/erbB4.
J Biol Chem
272:26761-26768[Abstract/Free Full Text].
-
Ewert M,
de Blas AL,
Mohler H,
Seeburg PH
(1992)
A prominent epitope on GABAA receptors is recognized by two different monoclonal antibodies.
Brain Res
569:57-62[Web of Science][Medline].
-
Falls DL,
Rosen KM,
Corfas G,
Lane WS,
Fischbach GD
(1993)
ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family.
Cell
72:801-815[Web of Science][Medline].
-
Gamett D,
Greene T,
Wagreich A,
Kim H,
Koland J,
Cerione R
(1995)
Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
J Biol Chem
270:19022-19027[Abstract/Free Full Text].
-
Gault LM,
Siegel RE
(1997)
Expression of the GABAA receptor delta subunit is selectively modulated by depolarization in cultured rat cerebellar granule neurons.
J Neurosci
17:2391-2399[Abstract/Free Full Text].
-
Ginty D,
Kornhauser J,
Thompson M,
Bading H,
Mayo K,
Takahashi J,
Greenberg M
(1993)
Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock.
Science
260:238-241[Abstract/Free Full Text].
-
Harris DA,
Falls DL,
Dill-Devor RM,
Fischbach GD
(1988)
Acetylcholine receptor-inducing factor from chicken brain increases the level of mRNA encoding the receptor alpha subunit.
Proc Natl Acad Sci USA
85:1983-1987[Abstract/Free Full Text].
-
Holmes WE,
Sliwkowski MX,
Akita RW,
Henzel WJ,
Lee J,
Park JW,
Yansura D,
Abadi N,
Raab H,
Lewis GD,
Shepard HM,
Kuang W-J,
Wood WI,
Goeddel DV,
Vandlen RL
(1992)
Identification of heregulin, a specific activator of p185erbB2.
Science
256:1205-1210[Abstract/Free Full Text].
-
Khrestchatisky M,
MacLennan AJ,
Chiang M-Y,
Xu W,
Jackson MB,
Brecha N,
Sternini C,
Olsen RW,
Tobin AJ
(1989)
A novel alpha subunit in rat brain GABAA receptors.
Neuron
3:745-753[Web of Science][Medline].
-
Laurie D,
Seeburg P,
Wisden W
(1992a)
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum.
J Neurosci
12:1063-1076[Abstract].
-
Laurie D,
Wisden W,
Seeburg P
(1992b)
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development.
J Neurosci
12:4151-4172[Abstract].
-
Lemke G
(1996)
Neuregulins in development.
Mol Cell Neurosci
7:247-262[Web of Science][Medline].
-
Lindholm D,
Dechant G,
Heisenberg CP,
Thoenen H
(1993)
Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity.
Eur J Neurosci
5:1455-1464[Web of Science][Medline].
-
Lindholm D,
Hamner S,
Zirrgiebel U
(1997)
Neurotrophins and cerebellar development.
Perspect Dev Neurobiol
5:83-94[Web of Science][Medline].
-
Luo X,
Kumar M,
Siegel R
(1998)
Expression of GABAA receptor subunits in cultured cerebellar granule neurons is dependent on the
2 subunit.
Soc Neurosci Abstr
24:1832. -
Marchionni MA,
Goodearl ADJ,
Chen MS,
Bermingham-McDonogh O,
Kirk C,
Hendricks M,
Danehy F,
Misumi D,
Sudhalter J,
Kobayashi K,
Wroblewski D,
Lynch C,
Baldassare M,
Hiles I,
Davis JB,
Hsuam JJ,
Totty NF,
Otsu M,
McBurney RN,
Waterfield MD,
Strootbent P,
Gwynne D
(1993)
Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system.
Nature
362:312-318[Medline].
-
Martinou J-C,
Falls DL,
Fischbach GD,
Merlie JP
(1991)
Acetylcholine receptor-inducing activity stimulates expression of the
-subunit gene of the muscle acetylcholine receptor.
Proc Natl Acad Sci USA
88:7669-7673[Abstract/Free Full Text]. -
Ozaki M,
Sasner M,
Yano R,
Lu HS,
Buonanno A
(1997)
Neuregulin-
induces expression of an NMDA-receptor subunit.
Nature
390:691-694[Medline]. -
Peles E,
Bacus SS,
Koski RA,
Lu HS,
Wen D,
Ogden SG,
Levy RB,
Yarden Y
(1992)
Isolation of the Neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
Cell
69:205-216[Web of Science][Medline].
-
Persohn E,
Malherbe P,
Richards J
(1992)
Comparative molecular neuroanatomy of cloned GABAA receptor subunits in the rat CNS.
J Comp Neurol
326:193-216[Web of Science][Medline].
-
Pinkas-Kramarski R,
Eilam R,
Spiegler O,
Lavi S,
Liu N,
Chang D,
Wen D,
Schwartz M,
Yarden Y
(1994)
Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes.
Proc Natl Acad Sci USA
91:9387-9391[Abstract/Free Full Text].
-
Pinkas-Kramarski R,
Eilam R,
Alroy I,
Levkowitz G,
Lonai P,
Yarden Y
(1997)
Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation.
Oncogene
15:2803-2815[Web of Science][Medline].
-
Plowman GD,
Culouscou J,
Whitney GS,
Green JM,
Carlton GW,
Foy L,
Neubauer MG,
Shoyab M
(1993)
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
Proc Natl Acad Sci USA
90:1746-1750[Abstract/Free Full Text].
-
Raetzman LT,
Siegel RE
(1999)
Immature granule neurons from cerebella of different ages exhibit distinct developmental potentials.
J Neurobiol
38:559-570[Web of Science][Medline].
-
Rio C,
Rieff HI,
Qi P,
Khurana TJ,
Corfas G
(1997)
Neuregulin and erbB receptors play a critical role in neuronal migration.
Neuron
19:39-50[Web of Science][Medline].
-
Sandrock AJ,
Dryer S,
Rosen K,
Gozani S,
Kramer R,
Theill L,
Fischbach G
(1997)
Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo.
Science
276:599-603[Abstract/Free Full Text].
-
Sandrock AWJ,
Goodearl AD,
Yin QW,
Chang D,
Fischbach GD
(1995)
ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses.
J Neurosci
15:6124-6136[Abstract].
-
Segal RA,
Takahashi H,
McKay R
(1992)
Changes in neurotrophin responsiveness during the development of cerebellar granule neurons.
Neuron
9:1041-1052[Web of Science][Medline].
-
Segal RA,
Pomeroy SL,
Stiles CD
(1995)
Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells.
J Neurosci
15:4970-4981[Abstract].
-
Shivers BD,
Killisch I,
Sprengel R,
Sontheimer H,
Kohler M,
Schofield PR,
Seeburg PH
(1989)
Two novel GABAA receptor subunits exist in distinct neuronal subpopulations.
Neuron
5:703-771.
-
Sundstrom P,
Deborah S,
Sypherd P
(1990)
Sequence analysis and expression of two genes for elongation factor 1-alpha from the dimorphic yeast Candida albician.
J Bacteriol
172:2036-2042[Abstract/Free Full Text].
-
Taberno A,
Stewart HJS,
Jessen KR,
Mirsky R
(1998)
The neuron-glia signal
-neuregulin induces sustained CREB phosphorylation on Ser-133 in cultured rat Schwann cells.
Mol Cell Neurosci
10:309-322. -
Vartanian T,
Corfas G,
Li Y,
Fischbach GD,
Stefansson K
(1994)
A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development.
Proc Natl Acad Sci USA
91:11626-11630[Abstract/Free Full Text].
-
Watanabe M,
Inoue Y,
Sakimura K,
Mishina M
(1992)
Developmental changes in distribution of NMDA receptor channel subunit mRNAs.
NeuroReport
3:1138-1140[Web of Science][Medline].
-
Watanabe M,
Mishina M,
Inoue Y
(1994)
Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum.
J Comp Neurol
343:513-519[Web of Science][Medline].
-
Wisden W
(1995)
Structure and distribution of multiple GABAA receptor subunits with special reference to the cerebellum.
Ann NY Acad Sci
757:506-515[Web of Science][Medline].
-
Yang X,
Kuo Y,
Devay P,
Yu C,
Role L
(1998)
A cysteine-rich isoform of neuregulin controls the levels of expression of neuronal nicotinic receptor channels during synaptogenesis.
Neuron
20:255-270[Web of Science][Medline].
-
Ymer S,
Schofield PR,
Draguhn A,
Werner P,
Kohler M,
Seeburg PH
(1989)
GABAA receptor
subunit heterogeneity: functional expression of cloned cDNAs.
EMBO J
8:1665-1670[Web of Science][Medline]. -
Yoshioka A,
Ikegaki N,
Williams M,
Pleasure D
(1996)
Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines.
J Neurosci Res
46:164-178[Web of Science][Medline].
-
Zhu XJ,
Lai C,
Thomas S,
Burden SJ
(1995)
Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses.
EMBO J
14:5842-5848[Web of Science][Medline].
Copyright © 1999 Society for Neuroscience 0270-6474/99/192410757-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Gajendran, J. P. Kapfhammer, E. Lain, M. Canepari, K. Vogt, W. Wisden, and H. R. Brenner
Neuregulin Signaling Is Dispensable for NMDA- and GABAA-Receptor Expression in the Cerebellum In Vivo
J. Neurosci.,
February 25, 2009;
29(8):
2404 - 2413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Krivosheya, L. Tapia, J. N. Levinson, K. Huang, Y. Kang, R. Hines, A. K. Ting, A. M. Craig, L. Mei, S. X. Bamji, et al.
ErbB4-Neuregulin Signaling Modulates Synapse Development and Dendritic Arborization through Distinct Mechanisms
J. Biol. Chem.,
November 21, 2008;
283(47):
32944 - 32956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hancock, S. E. Canetta, L. W. Role, and D. A. Talmage
Presynaptic Type III Neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons
J. Cell Biol.,
October 14, 2008;
181(3):
511 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. B. Kwon, D. Paredes, C. M. Gonzalez, J. Neddens, L. Hernandez, D. Vullhorst, and A. Buonanno
Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors
PNAS,
October 7, 2008;
105(40):
15587 - 15592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. J. Chen, M. A. Johnson, M. D. Lieberman, R. E. Goodchild, S. Schobel, N. Lewandowski, G. Rosoklija, R.-C. Liu, J. A. Gingrich, S. Small, et al.
Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components
J. Neurosci.,
July 2, 2008;
28(27):
6872 - 6883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Hsieh, T. E. Dick, and R. E. Siegel
Adaptation to hypobaric hypoxia involves GABAA receptors in the pons
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2008;
294(2):
R549 - R557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Law, J. E. Kleinman, D. R. Weinberger, and C. S. Weickert
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia
Hum. Mol. Genet.,
January 15, 2007;
16(2):
129 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Chang and G. D. Fischbach
An Acute Effect of Neuregulin 1beta to Suppress {alpha}7-Containing Nicotinic Acetylcholine Receptors in Hippocampal Interneurons.
J. Neurosci.,
November 1, 2006;
26(44):
11295 - 11303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carteron, A. Ferrer-Montiel, and H. Cabedo
Characterization of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival
J. Cell Sci.,
March 1, 2006;
119(5):
898 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, M. Sato, Y. Morishima, and S. Nakanishi
Neuronal Depolarization Controls Brain-Derived Neurotrophic Factor-Induced Upregulation of NR2C NMDA Receptor via Calcineurin Signaling
J. Neurosci.,
October 12, 2005;
25(41):
9535 - 9543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tosato, P. Dazzan, and D. Collier
Association Between the Neuregulin 1 Gene and Schizophrenia: A Systematic Review
Schizophr Bull,
July 1, 2005;
31(3):
613 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gu, Q. Jiang, A. K. Y. Fu, N. Y. Ip, and Z. Yan
Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex
J. Neurosci.,
May 18, 2005;
25(20):
4974 - 4984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Pearson Jr. and S. L. Carroll
ErbB Transmembrane Tyrosine Kinase Receptors Are Expressed by Sensory and Motor Neurons Projecting into Sciatic Nerve
J. Histochem. Cytochem.,
October 1, 2004;
52(10):
1299 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Patten, J. M. Peyrin, G. Weinmaster, and G. Corfas
Sequential Signaling through Notch1 and erbB Receptors Mediates Radial Glia Differentiation
J. Neurosci.,
July 9, 2003;
23(14):
6132 - 6140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Cheng and H. H Yeh
Brain-derived neurotrophic factor attenuates mouse cerebellar granule cell GABAA receptor-mediated responses via postsynaptic mechanisms
J. Physiol.,
May 1, 2003;
548(3):
711 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Yau, H.-F. Wang, C. Lai, and F.-C. Liu
Neural Development of the Neuregulin Receptor ErbB4 in the Cerebral Cortex and the Hippocampus: Preferential Expression by Interneurons Tangentially Migrating from the Ganglionic Eminences
Cereb Cortex,
March 1, 2003;
13(3):
252 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Goldshmit, S. Erlich, and R. Pinkas-Kramarski
Neuregulin Rescues PC12-ErbB4 Cells from Cell Death Induced by H2O2. REGULATION OF REACTIVE OXYGEN SPECIES LEVELS BY PHOSPHATIDYLINOSITOL 3-KINASE
J. Biol. Chem.,
November 30, 2001;
276(49):
46379 - 46385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bennett and A. J. Baines
Spectrin and Ankyrin-Based Pathways: Metazoan Inventions for Integrating Cells Into Tissues
Physiol Rev,
July 1, 2001;
81(3):
1353 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Cheng, J. C. Kulli, and J. Yang
Suppression of Neuronal Hyperexcitability and Associated Delayed Neuronal Death by Adenoviral Expression of GABAC Receptors
J. Neurosci.,
May 15, 2001;
21(10):
3419 - 3428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ozaki
Neuregulins and the Shaping of Synapses
Neuroscientist,
April 1, 2001;
7(2):
146 - 154.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Cameron, L. Dryer, and S. E. Dryer
beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons
PNAS,
February 1, 2001;
(2001)
41394098.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Z. Huang, Q. Wang, W. C. Xiong, and L. Mei
Erbin Is a Protein Concentrated at Postsynaptic Membranes That Interacts with PSD-95
J. Biol. Chem.,
May 25, 2001;
276(22):
19318 - 19326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Cameron, L. Dryer, and S. E. Dryer
beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons
PNAS,
February 27, 2001;
98(5):
2832 - 2836.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|